You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 21, November 27, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

Tea and Coronary Heart Disease: Protection Through Estrogenlike Activity?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Tea drinking appears to be protective against coronary heart disease in a number of epidemiologic studies. It has been suggested that tea flavonols with antioxidative activity, including quercetin, kaempferol, and myricetin,1 could account for the favorable effect on cardiovascular health.

In the older cohort of the Rotterdam Study, we observed an inverse association of tea drinking with severe aortic atherosclerosis.2 Interestingly, the relationship was most pronounced in women, which raised the hypothesis that an estrogen-related mechanism could be involved. Tea drinking in another population-based study of older women appeared protective against bone mineral loss, which may also indicate estrogenicity.3 Tea flavonoids such as kaempferol have indeed been shown to exhibit estrogenic activity in vitro.4 Daily kaempferol intake is almost doubled in regular tea drinkers compared with nondrinkers (a 6-mg increase for 3 to 4 cups of tea). In addition, tea contains lignan polyphenols, such as secoisolaracinol, which have been considered . . . [Full Text of this Article]


RELATED ARTICLE

Tea Flavonoids May Protect Against Atherosclerosis: The Rotterdam Study
Johanna M. Geleijnse, Lenore J. Launer, Albert Hofman, Huibert A. P. Pols, and Jacqueline C. M. Witteman
Arch Intern Med. 1999;159(18):2170-2174.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coffee Consumption and Coronary Calcification: The Rotterdam Coronary Calcification Study
van Woudenbergh et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1018-1023.
ABSTRACT | FULL TEXT  

Tea Consumption Is Inversely Associated With Carotid Plaques in Women
Debette et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:353-359.
ABSTRACT | FULL TEXT  

Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies
Sun et al.
Carcinogenesis 2006;27:1310-1315.
ABSTRACT | FULL TEXT  

Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore
Wu et al.
Carcinogenesis 2005;26:976-980.
ABSTRACT | FULL TEXT  

Tea Intake Is Inversely Related to Blood Pressure in Older Women
Hodgson et al.
J. Nutr. 2003;133:2883-2886.
ABSTRACT | FULL TEXT  

Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: A Randomized Controlled Trial
Maron et al.
Arch Intern Med 2003;163:1448-1453.
ABSTRACT | FULL TEXT  

Flavonoid intake and the risk of cardiovascular disease in women
Sesso et al.
Am. J. Clin. Nutr. 2003;77:1400-1408.
ABSTRACT | FULL TEXT  

Tea and Coronary Heart Disease: the Flavonoid Quercetin Is More Bioavailable From Rutin in Women Than in Men
Erlund et al.
Arch Intern Med 2001;161:1919-1920.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.